Search clinical trials for: NBI-921352

Total 2486 results

National Research Council, Spain
Hospital Universitario 12 de Octubre

Completed

Food Anthocyanins and Flavanols as a Strategy for a Healthy Ageing: Cardiovascular Health and Cognitive Performance (POLYAGE)

Healthy Aging

Spain
Wuerzburg University Hospital

Unknown

Combined Subthalamic and Nucleus Basalis Meynert Deep Brain Stimulation for Parkinson's Disease With Dementia (Dempark-DBS)

Parkinson Disease | Dementia

Germany
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Enhancing Emergency Practitioner (EP)-Performed Alcohol Interventions in the Emergency Department (ED)

Harmful Drinking

United States
Celgene

Completed

Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
Eleven Biotherapeutics

Completed

Phase 3 Study of EBI-005 in Dry Eye Disease (EBI-005)

Dry Eye Disease (DED)

United States
MetroHealth Medical Center
The Cleveland Music School Settlement; Kulas Foundation

Completed

Efficacy of Music Therapy Protocols for Burn Debridement (MTS1)

Pain Management

United States
Indiana University School of Medicine

Completed

Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.

Cataract

United States
Boehringer Ingelheim

Completed

Bioavailability of Four Oral Prototype Extended Release Formulations With BI 11634 in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours)

Neoplasm

Japan
University of Dundee
NHS Tayside

Completed

Narrowband Ultraviolet B Versus Narrowband Ultraviolet B Plus Ultraviolet A1 for Atopic Eczema

Atopic Eczema

United Kingdom
University of Reading
Danisco

Completed

The Effect of a Prebiotic, Probiotic and Synbiotic on the Gut Microbiota and Immune Response of Older Volunteers (GOS)

Gut Microbiota | Immune Function

United Kingdom
Boehringer Ingelheim

Completed

Relative Bioavailability of Different Formulations of BI 671800 in Healthy Male and Female Volunteers

Healthy
Children's Hospital of Eastern Ontario
University of Ottawa; Academic Health Science Centres; Mobio Interactive PTE LTD

Recruiting

Mindfulness-Based Intervention for Mild Traumatic Brain Injury (MBI-4-mTBI)

Concussion, Mild

Canada
Fresh Tracks Therapeutics, Inc.

Completed

A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects

Dermatitis, Atopic

United States
Lindenwood University
Increnovo, LLC

Completed

Changes in Plasma Amino Acid Appearance After Adding Bacillus Coagulans GBI-30, 6086 to Milk Protein Concentrate (ABC)

Protein Malabsorption

United States
Beijing Chest Hospital
Shandong Chest Hospital; Zhengzhou Sixth People's Hospital

Active, not recruiting

Early Bactericidal Activity Safety Pulmonary Tuberculosis Pyrifazimine (TBI-166)

Sensitive Pulmonary Tuberculosis

China
University of Massachusetts, Amherst

Completed

A Tablet-based Simple Walking Intervention

Fatigue | Arthritis

United States
Celgene Corporation

Completed

Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Yuankai Shi

Unknown

Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma

Peripheral T Cell Lymphoma
Sheba Medical Center

Unknown

Evaluating the Physiological Strain Induced by a BC Membrane Protective Garment Under Exercise-heat Stress Compared to a Protective Coverall

Physiological Stress

Israel
Allergan

Completed

A Study of Bimatoprost 0.01% in the Clinical Setting (APPEAL-Taiwan)

Ocular Hypertension | Glaucoma, Primary Open Angle

Taiwan
University of Houston
Baylor College of Medicine; National Institute on Minority Health and Health... and other collaborators

Recruiting

Smoking, Stress, HIV and Mobile Technology

Cigarette Smoking

United States
Mayo Clinic

Completed

Pilot Study: Combined Molecular Breast Imaging/Ultrasound System for Diagnostic Evaluation of MBI-detected Lesions (MBI/US)

Breast Cancer

United States
Fresh Tracks Therapeutics, Inc.

Completed

Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis (BBI)

Contact Dermatitis

Canada
Celgene

Completed

Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma

Melanoma | Metastases

United States
Celgene Corporation

Completed

ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer

Breast Neoplasms | Metastases, Neoplasm

United States
Celgene Corporation

Completed

A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies

Neoplasms | Metastases, Neoplasm

United States
Maharishi Markendeswar University (Deemed to be...

Completed

A Clinical Trial to Study the Effect of Imagined Progressive Movements in Patients With Paralysis of One Side of the Body.

Stroke

India
Taiho Pharmaceutical Co., Ltd.

Completed

Phase II Study of ABI-007 for Gastric Cancer

Gastric Cancer

Japan
Boehringer Ingelheim

Completed

Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers

Schizophrenia | Alzheimer Disease

United States
Boehringer Ingelheim

Recruiting

A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Solid Tumor, KRAS Mutation

United States, Taiwan, Japan
Boehringer Ingelheim

Recruiting

A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3

Glioma

United States, Switzerland, Germany
Boehringer Ingelheim

Completed

A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours

Neoplasms

United States, Canada, United Kingdom
Boehringer Ingelheim

Completed

A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer

Gastrointestinal Neoplasms | Pancreatic Neoplasms | Cholangiocarcinoma

Spain, Belgium, China, United States, Germany, Korea, Republic of, France, Japan
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How BI 1810631 is Taken up in the Body When Taken With or Without Food

Healthy

Germany
University of Pennsylvania

Withdrawn

Usability Testing of a Bilateral Activities of Daily Exercise Robot for Stroke Therapy (BiADLER)

Stroke | Cerebral Palsy

United States
Boehringer Ingelheim

Completed

A Study to Test Different Doses of BI 3011441 in Japanese People With Different Types of Advanced Cancer (NRAS/KRAS Mutation Positive)

Solid Tumors, KRAS Mutation

Japan
Boehringer Ingelheim

Completed

BI 2536 Second Line Monotherapy in SCLC

Carcinoma, Small Cell

United States, Canada
Boehringer Ingelheim

Completed

A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy Men

Healthy

Germany
Boehringer Ingelheim

Completed

Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid Cancers

Neoplasms

Taiwan
Boehringer Ingelheim

Completed

Relative Bioavailability of BI 1015550 Following Oral Administration Under Fed and Fasted Conditions in Healthy Male Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours and Later a Weekly Dosing Schedule in Selected Tumour Types

Neoplasms

United Kingdom
Boehringer Ingelheim

Completed

A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer

Neoplasms

Canada, Netherlands
Boehringer Ingelheim

Completed

Pharmacokinetics and Safety of BI 201335 in Patients With Mild to Severe Renal Impairment

Hepatitis C

Germany
Boehringer Ingelheim

Completed

A Study of BI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic Cancer

Neoplasms

Japan, Taiwan
Boehringer Ingelheim

Completed

BI 2536 Infusional Treatment in Patients Over 60 Years of Age With Refractory or Relapsed Acute Myeloid Leukaemia

Leukemia, Myeloid, Acute

Austria, Germany
Boehringer Ingelheim

Completed

Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food

Healthy

Germany
Boehringer Ingelheim

Completed

Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)

Lymphoma

United States
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1026706 in Male and Female Healthy Subjects and Patients With Osteoarthritis of the Knee

Osteoarthritis

Germany
Boehringer Ingelheim

Completed

Trial to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI135585 XX Administered as Tablet and as Solution in Healthy Volunteers

Diabetes Mellitus, Type 2

Germany

3

Subscribe